PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB
Blood Adv
.
2025 Jan 18:bloodadvances.2024014928.
doi: 10.1182/bloodadvances.2024014928.
Online ahead of print.
Authors
Carlos A Torres-Cabala
1
,
Julia Yescas
2
,
Yue Zhang
3
,
Auris Huen
1
,
Sumit Gaur
4
,
Kristy Tefft
2
,
Guiling Tang
5
,
Jonathan L Curry
6
,
Jillian R Gunther
6
,
Bouthaina S Dabaja
6
,
Swaminathan P Iyer
6
,
Roberto Nicolas Miranda
7
,
Jaehyuk Choi
2
,
Valentina Nardi
8
Affiliations
1
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.
2
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
3
Northwestern University, United States.
4
Texas Tech University Health Sciences Center El Paso, El Paso, Texas, United States.
5
UT MD Anderson Cancer Center, Houston, Texas, United States.
6
MD Anderson Cancer Center, Houston, Texas, United States.
7
The University of Texas MD Anderson Cancer Center, Cedar Park, Texas, United States.
8
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
PMID:
39825823
DOI:
10.1182/bloodadvances.2024014928
No abstract available